Advertisement

An Innovative Strategy for the Effective Reduction of MDR Pathogens from the Nosocomial Environment

  • Elisabetta CaselliEmail author
  • Maria D’Accolti
  • Irene Soffritti
  • Luca Lanzoni
  • Matteo Bisi
  • Antonella Volta
  • Filippo Berloco
  • Sante Mazzacane
Chapter
  • 150 Downloads
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1214)

Abstract

Antimicrobial resistance (AMR) is currently one of the main concerns for human health.

Due to its rapid increase and global diffusion, several common microbial infections might become not curable in the future decades, making it impossible to apply other lifesaver therapies, such as transplant or chemotherapy.

AMR is frequently observed in hospital pathogens, due to selective pressure exerted by antibiotic use, and consistently with this, in the recent years, many actions have been proposed to limit AMR spread, including hygiene measures for hospital professionals and a wiser antibiotic usage.

Indeed, the hospital environment itself represents a reservoir of pathogens, whose control was so far addressed by conventional sanitation procedures, which however cannot prevent recontamination and might further favour the selection of resistant strains.

Here we report the results collected by studying an innovative sanitation strategy based on the use of probiotic bacteria, capable of reducing in a stable way the surface load of pathogens and their AMR. Collected data suggest that this system might contribute significantly to AMR control and might be thus considered as one of the tools for AMR and infection prevention and control.

Keywords

Antimicrobial resistance Healthcare-associated infections Hospital environment Probiotics Sanitation strategy 

References

  1. Alividza V, Mariano V, Ahmad R, Charani E, Rawson TM, Holmes AH et al (2018) Investigating the impact of poverty on colonization and infection with drug-resistant organisms in humans: a systematic review. Infect Dis Poverty 7(1):76.  https://doi.org/10.1186/s40249-018-0459-7 CrossRefPubMedPubMedCentralGoogle Scholar
  2. Almatroudi A, Gosbell IB, Hu H, Jensen SO, Espedido BA, Tahir S et al (2016) Staphylococcus aureus dry-surface biofilms are not killed by sodium hypochlorite: implications for infection control. J Hosp Infect 93(3):263–270.  https://doi.org/10.1016/j.jhin.2016.03.020 CrossRefPubMedGoogle Scholar
  3. Alp E, Damani N (2015) Healthcare-associated infections in intensive care units: epidemiology and infection control in low-to-middle income countries. J Infect Dev Ctries 9(10):1040–1045.  https://doi.org/10.3855/jidc.6832 CrossRefPubMedGoogle Scholar
  4. Banerjee T, Mishra A, Das A, Sharma S, Barman H, Yadav G (2018) High prevalence and Endemicity of multidrug resistant Acinetobacter spp. in Intensive Care Unit of a Tertiary Care Hospital, Varanasi, India. J Pathog 2018:9129083.  https://doi.org/10.1155/2018/9129083 CrossRefPubMedPubMedCentralGoogle Scholar
  5. Banupriya B, Biswal N, Srinivasaraghavan R, Narayanan P, Mandal J (2015) Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial. Intensive Care Med 41(4):677–685.  https://doi.org/10.1007/s00134-015-3694-4 CrossRefPubMedGoogle Scholar
  6. Bock LJ, Wand ME, Sutton JM (2016) Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains. J Hosp Infect 93(1):42–48.  https://doi.org/10.1016/j.jhin.2015.12.019 CrossRefPubMedGoogle Scholar
  7. Bragg RR, Meyburgh CM, Lee JY, Coetzee M (2018) Potential treatment options in a post-antibiotic era. Adv Exp Med Biol 1052:51–61.  https://doi.org/10.1007/978-981-10-7572-8_5 CrossRefPubMedGoogle Scholar
  8. Bush K, Jacoby GA (2010) Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 54(3):969–976.  https://doi.org/10.1128/AAC.01009-09 CrossRefPubMedGoogle Scholar
  9. Caini S, Hajdu A, Kurcz A, Borocz K (2013) Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005-2010. Euro Surveill 18(2). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=23324427
  10. Caselli E (2017) Hygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings. Microb Biotechnol 10(5):1079–1083.  https://doi.org/10.1111/1751-7915.12755 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Caselli E, Antonioli P, Mazzacane S (2016a) Safety of probiotics used for hospital environmental sanitation. J Hosp Infect 94(2):193–194.  https://doi.org/10.1016/j.jhin.2016.06.021 CrossRefPubMedGoogle Scholar
  12. Caselli E, D’Accolti M, Vandini A, Lanzoni L, Camerada MT, Coccagna M et al (2016b) Impact of a probiotic-based cleaning intervention on the microbiota ecosystem of the hospital surfaces: focus on the Resistome Remodulation. PLoS One 11(2):e0148857.  https://doi.org/10.1371/journal.pone.0148857 CrossRefPubMedPubMedCentralGoogle Scholar
  13. Caselli E, Brusaferro S, Coccagna M, Arnoldo L, Berloco F, Antonioli P et al (2018a) Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: a multicentre, prospective, intervention study. PLoS One 13(7):e0199616.  https://doi.org/10.1371/journal.pone.0199616 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Caselli E, D’Accolti M, Soffritti I, Piffanelli M, Mazzacane S (2018b) Spread of mcr-1-driven Colistin resistance on hospital surfaces, Italy. Emerg Infect Dis 24(9):1752–1753.  https://doi.org/10.3201/eid2409.171386 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Caselli E, Pancaldi S, Baldisserotto C, Petrucci F, Impallaria A, Volpe L et al (2018c) Characterization of biodegradation in a 17th century easel painting and potential for a biological approach. PLoS One 13(12):e0207630.  https://doi.org/10.1371/journal.pone.0207630 CrossRefPubMedPubMedCentralGoogle Scholar
  16. Caselli E, Arnoldo L, Rognoni C, D’Accolti M, Soffritti I, Lanzoni L et al (2019) Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multi-center study. Infection Drug Resist 12:501–510CrossRefGoogle Scholar
  17. Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T et al (2016) Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med 13(10):e1002150.  https://doi.org/10.1371/journal.pmed.1002150 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Cassini A, Hogberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS et al (2019) Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis 19(1):56–66.  https://doi.org/10.1016/S1473-3099(18)30605-4 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Chowdhury D, Tahir S, Legge M, Hu H, Prvan T, Johani K et al (2018) Transfer of dry surface biofilm in the healthcare environment: the role of healthcare workers’ hands as vehicles. J Hosp Infect 100(3):e85–e90.  https://doi.org/10.1016/j.jhin.2018.06.021 CrossRefPubMedGoogle Scholar
  20. Cornejo-Juarez P, Vilar-Compte D, Perez-Jimenez C, Namendys-Silva SA, Sandoval-Hernandez S, Volkow-Fernandez P (2015) The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis 31:31–34. doi:S1201-9712(14)01740-8 [pii]CrossRefGoogle Scholar
  21. Costa DM, Johani K, Melo DS, Lopes LKO, Lopes Lima LKO, Tipple AFV et al (2019) Biofilm contamination of high-touched surfaces in intensive care units: epidemiology and potential impacts. Lett Appl Microbiol 68(4):269–276.  https://doi.org/10.1111/lam.13127 CrossRefPubMedGoogle Scholar
  22. Cutting SM (2011) Bacillus probiotics. Food Microbiol 28(2):214–220.  https://doi.org/10.1016/j.fm.2010.03.007 CrossRefPubMedGoogle Scholar
  23. ECDC (2013) Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf
  24. ECDC (2017a) A European one health action plan against antimicrobial resistance (AMR). European Commission. https://ec.europa.eu/health/amr/sites/amr/files/amr_action_plan_2017_en.pdf
  25. ECDC (2017b) Surveillance of antimicrobial resistance in Europe – 2017. www.ecdc.europa.eu. https://ecdc.europa.eu/sites/portal/files/documents/EARS-Net-report-2017-update-jan-2019.pdf
  26. EFSA (2010) Panel on Biological Hazards (BIOHAZ). Scientific opinion on the maintenance of the list of QPS microorganisms intentionally added to food or feed (2010 update). EFSA J 8.  https://doi.org/10.2903/j.efsa.2010.1944
  27. Europe W (2017) Hand hygiene a key defence in Europe’s fight against antibiotic resistance. WHO Regional Office for Europe. http://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/news/news/2017/05/hand-hygiene-a-key-defence-in-europes-fight-against-antibiotic-resistance
  28. Ferjani S, Saidani M, Amine FS, Boutiba Ben Boubaker I (2015) A comparative study of antimicrobial resistance rates and phylogenetic groups of community-acquired versus hospital-acquired invasive Escherichia coli. Med Mal Infect 45(4):133–138.  https://doi.org/10.1016/j.medmal.2015.01.012 CrossRefPubMedGoogle Scholar
  29. Ghelardi E, Celandroni F, Salvetti S, Gueye SA, Lupetti A, Senesi S (2015) Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. J Appl Microbiol 119(2):552–559.  https://doi.org/10.1111/jam.12848 CrossRefPubMedGoogle Scholar
  30. Giamarellos-Bourboulis EJ, Bengmark S, Kanellakopoulou K, Kotzampassi K (2009) Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 67(4):815–821.  https://doi.org/10.1097/TA.0b013e31819d979e CrossRefPubMedGoogle Scholar
  31. Glance LG, Stone PW, Mukamel DB, Dick AW (2011) Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch Surg 146(7):794–801.  https://doi.org/10.1001/archsurg.2011.41 CrossRefPubMedPubMedCentralGoogle Scholar
  32. Gould DJ, Moralejo D, Drey N, Chudleigh JH, Taljaard M (2017) Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev 9:CD005186.  https://doi.org/10.1002/14651858.CD005186.pub4 CrossRefPubMedGoogle Scholar
  33. Haque M, Sartelli M, McKimm J, Abu Bakar M (2018) Health care-associated infections – an overview. Infect Drug Resist 11:2321–2333.  https://doi.org/10.2147/IDR.S177247 CrossRefPubMedPubMedCentralGoogle Scholar
  34. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA et al (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29(11):996–1011.  https://doi.org/10.1086/591861 CrossRefPubMedGoogle Scholar
  35. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B et al (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506–514.  https://doi.org/10.1038/nrgastro.2014.66 CrossRefPubMedGoogle Scholar
  36. Hu H, Johani K, Gosbell IB, Jacombs AS, Almatroudi A, Whiteley GS et al (2015) Intensive care unit environmental surfaces are contaminated by multidrug-resistant bacteria in biofilms: combined results of conventional culture, pyrosequencing, scanning electron microscopy, and confocal laser microscopy. J Hosp Infect 91(1):35–44.  https://doi.org/10.1016/j.jhin.2015.05.016 CrossRefPubMedGoogle Scholar
  37. Johani K, Abualsaud D, Costa DM, Hu H, Whiteley G, Deva A et al (2018) Characterization of microbial community composition, antimicrobial resistance and biofilm on intensive care surfaces. J Infect Public Health 11(3):418–424.  https://doi.org/10.1016/j.jiph.2017.10.005 CrossRefPubMedGoogle Scholar
  38. Klepser ME, Dobson EL, Pogue JM, Labreche MJ, Adams AJ, Gauthier TP et al (2017) A call to action for outpatient antibiotic stewardship. J Am Pharm Assoc 57(4):457–463.  https://doi.org/10.1016/j.japh.2017.03.013 CrossRefGoogle Scholar
  39. Ledwoch K, Dancer SJ, Otter JA, Kerr K, Roposte D, Rushton L et al (2018) Beware biofilm! Dry biofilms containing bacterial pathogens on multiple healthcare surfaces; a multi-centre study. J Hosp Infect 100(3):e47–e56.  https://doi.org/10.1016/j.jhin.2018.06.028 CrossRefPubMedGoogle Scholar
  40. Leyva Salas M, Mounier J, Valence F, Coton M, Thierry A, Coton E (2017) Antifungal microbial agents for food biopreservation-a review. Microorganisms 5(3):37.  https://doi.org/10.3390/microorganisms5030037 CrossRefPubMedCentralGoogle Scholar
  41. Lopetuso LR, Scaldaferri F, Franceschi F, Gasbarrini A (2016) Bacillus clausii and gut homeostasis: state of the art and future perspectives. Expert Rev Gastroenterol Hepatol 10(8):943–948.  https://doi.org/10.1080/17474124.2016.1200465 CrossRefPubMedGoogle Scholar
  42. Mazza P (1994) The use of Bacillus subtilis as an antidiarrhoeal microorganism. Boll Chim Farm 133:3–18PubMedGoogle Scholar
  43. Messina AF, Berman DM, Ghazarian SR, Patel R, Neustadt J, Hahn G et al (2014) The management and outcome of spinal implant-related infections in pediatric patients: a retrospective review. Pediatr Infect Dis J 33(7):720–723.  https://doi.org/10.1097/INF.0000000000000264 CrossRefPubMedGoogle Scholar
  44. Mingmongkolchai S, Panbangred W (2018) Bacillus probiotics: an alternative to antibiotics for livestock production. J Appl Microbiol 124(6):1334–1346.  https://doi.org/10.1111/jam.13690 CrossRefPubMedGoogle Scholar
  45. Monnier AA, Eisenstein BI, Hulscher ME, Gyssens IC, Group, D.-A. W (2018) Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure. J Antimicrob Chemother 73(suppl_6):vi3–vi16.  https://doi.org/10.1093/jac/dky114 CrossRefPubMedPubMedCentralGoogle Scholar
  46. O’Neill J (2014) Review on antimicrobial resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014. https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf
  47. OECD, & Union, E (2016) Health at a Glance: Europe 2016: state of the health in the EU cycle. OECD Publishing, ParisCrossRefGoogle Scholar
  48. Parajuli NP, Acharya SP, Mishra SK, Parajuli K, Rijal BP, Pokhrel BM (2017) High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control 6:67.  https://doi.org/10.1186/s13756-017-0222-z CrossRefPubMedPubMedCentralGoogle Scholar
  49. Piewngam P, Zheng Y, Nguyen TH, Dickey SW, Joo HS, Villaruz AE et al (2018) Pathogen elimination by probiotic Bacillus via signalling interference. Nature 562(7728):532–537.  https://doi.org/10.1038/s41586-018-0616-y CrossRefPubMedPubMedCentralGoogle Scholar
  50. Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F et al (2001) In vitro anti-helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 45(11):3156–3161.  https://doi.org/10.1128/AAC.45.11.3156-3161.2001 CrossRefPubMedPubMedCentralGoogle Scholar
  51. Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S et al (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74(1):123–127. https://www.ncbi.nlm.nih.gov/pubmed/12134110 CrossRefGoogle Scholar
  52. Rayes N, Pilarski T, Stockmann M, Bengmark S, Neuhaus P, Seehofer D (2012) Effect of pre- and probiotics on liver regeneration after resection: a randomised, double-blind pilot study. Benefic Microbes 3(3):237–244.  https://doi.org/10.3920/BM2012.0006 CrossRefGoogle Scholar
  53. Revelas A (2012) Healthcare – associated infections: a public health problem. Niger Med J 53(2):59–64.  https://doi.org/10.4103/0300-1652.103543 CrossRefPubMedPubMedCentralGoogle Scholar
  54. Rice LB (2008) Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 197(8):1079–1081.  https://doi.org/10.1086/533452 CrossRefPubMedGoogle Scholar
  55. Ripert G, Racedo SM, Elie AM, Jacquot C, Bressollier P, Urdaci MC (2016) Secreted compounds of the probiotic Bacillus clausii strain O/C inhibit the cytotoxic effects induced by Clostridium difficile and Bacillus cereus toxins. Antimicrob Agents Chemother 60(6):3445–3454.  https://doi.org/10.1128/AAC.02815-15 CrossRefPubMedPubMedCentralGoogle Scholar
  56. Rutala WA, Weber DJ (2014) Selection of the ideal disinfectant. Infect Control Hosp Epidemiol 35(7):855–865.  https://doi.org/10.1086/676877 CrossRefPubMedGoogle Scholar
  57. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A et al (2013) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34(1):1–14.  https://doi.org/10.1086/668770 CrossRefPubMedGoogle Scholar
  58. Sommacal HM, Bersch VP, Vitola SP, Osvaldt AB (2015) Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial. Nutr Cancer 67(3):457–462.  https://doi.org/10.1080/01635581.2015.1004734 CrossRefPubMedGoogle Scholar
  59. Sorokulova IB, Kirik DL, Pinchuk II (1997) Probiotics against campylobacter pathogens. J Travel Med 4(4):167–170. https://www.ncbi.nlm.nih.gov/pubmed/9815508 CrossRefGoogle Scholar
  60. Suetens C, Hopkins S, Kolman J, Diaz Högberg L (2013) Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals. European Centre for Disease Prevention and Control, Stockholm. http://www.ecdc.europa.eu/en/publications/publications/healthcare-associated-infections-antimicrobial-usepps.pdf Google Scholar
  61. Sydnor ER, Perl TM (2011) Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 24(1):141–173.  https://doi.org/10.1128/CMR.00027-10 CrossRefPubMedPubMedCentralGoogle Scholar
  62. Vandini A, Temmerman R, Frabetti A, Caselli E, Antonioli P, Balboni PG et al (2014) Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One 9(9):e108598.  https://doi.org/10.1371/journal.pone.0108598 CrossRefPubMedPubMedCentralGoogle Scholar
  63. Vaseeharan B, Ramasamy P (2003) Control of pathogenic Vibrio spp. by Bacillus subtilis BT23, a possible probiotic treatment for black tiger shrimp Penaeus monodon. Lett Appl Microbiol 36(2):83–87. https://www.ncbi.nlm.nih.gov/pubmed/12535126 CrossRefGoogle Scholar
  64. Wand ME, Bock LJ, Bonney LC, Sutton JM (2017) Mechanisms of increased resistance to chlorhexidine and cross-resistance to Colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother 61(1).  https://doi.org/10.1128/AAC.01162-16
  65. Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ et al (2016) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 37(11):1288–1301.  https://doi.org/10.1017/ice.2016.174 CrossRefPubMedPubMedCentralGoogle Scholar
  66. WHO (2015) Global action plan on antimicrobial resistance. WHO Library Cataloguing-in-Publicatio Data. http://apps.who.int/iris/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1
  67. WHO (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/
  68. WHO & FDA (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. World Health Organization [online]. Available at: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf
  69. Xu S, Lin Y, Zeng D, Zhou M, Zeng Y, Wang H et al (2018) Bacillus licheniformis normalize the ileum microbiota of chickens infected with necrotic enteritis. Sci Rep 8(1):1744.  https://doi.org/10.1038/s41598-018-20059-z CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Elisabetta Caselli
    • 1
    • 2
    Email author
  • Maria D’Accolti
    • 1
    • 2
  • Irene Soffritti
    • 1
    • 2
  • Luca Lanzoni
    • 2
  • Matteo Bisi
    • 2
  • Antonella Volta
    • 2
  • Filippo Berloco
    • 3
  • Sante Mazzacane
    • 2
  1. 1.Section of Microbiology and Medical Genetics, Department of Medical SciencesUniversity of FerraraFerraraItaly
  2. 2.CIAS Research CenterUniversity of FerraraFerraraItaly
  3. 3.Fondazione Policlinico Universitario A. GemelliRomeItaly

Personalised recommendations